Hypoglycaemia in a patient with diabetes
58 results
1 - 58
(Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus- (Ultra‐)long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus
- Continuous glucose monitoring systems for type 1 diabetes mellitus
- Interventions for people with type 2 diabetes mellitus fasting during Ramadan
- Sulphonylurea monotherapy for patients with type 2 diabetes mellitus: Cochrane systematic review
- Insulin for glycaemic control in acute ischaemic stroke: Cochrane systematic review
- Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
- Dipeptidyl peptidase‐4 (DPP‐4) inhibitors for type 2 diabetes mellitus
- Short‐acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus
- Intermediate acting versus long acting insulin for type 1 diabetes mellitus
- 'Human' insulin versus animal insulin in people with diabetes mellitus
- Glucose‐lowering agents for treating pre‐existing and new‐onset diabetes in kidney transplant recipients
- Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus: Cochrane systematic review
- Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia
- Inhaled insulin in diabetes mellitus: Cochrane systematic review
- Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus
- Education programmes for people with chronic kidney disease and diabetes
- Insulin detemir versus insulin glargine for type 2 diabetes mellitus: Cochrane systematic review
- Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus: Cochrane systematic review
- Routine hospital admission versus out‐patient or home care in children at diagnosis of type 1 diabetes mellitus
- Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents
- Specialist nurses in diabetes mellitus: Cochrane systematic review
- Sodium‐glucose co‐transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes
- Glucagon‐like peptide 1 (GLP‐1) receptor agonists for people with chronic kidney disease and diabetes
- Meglitinide analogues for type 2 diabetes mellitus
- Glucose targets for preventing diabetic kidney disease and its progression
- Short‐acting insulin analogues versus regular human insulin for adult, non‐pregnant persons with type 2 diabetes mellitus
- Metformin and second‐ or third‐generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus
- Low glycaemic index, or low glycaemic load, diets for diabetes mellitus
- Self‐monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin
- Ayurvedic treatments for diabetes mellitus: Cochrane systematic review
- Glucagon-like peptide analogues for type 2 diabetes mellitus: Cochrane systematic review
- Quality improvement strategies for diabetes care: Effects on outcomes for adults living with diabetes
- Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus
- Dipeptidyl peptidase‐4 inhibitors, glucagon‐like peptide 1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors for people with cardiovascular disease: a network meta‐analysis
- Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control